Work

European Medicines Agency approvals of new medicines in September and October 2026

Year: 2026

Type: article

Abstract: In September and October 2026, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the granting of an EU-wide authorisation for 11 new medicines (Table 1) and 4 new biosimilar medicines (Table 2). The CHMP also recommended the authorisation of 3 new generic medicines and new indications for 16 medicines already authorised in the EU.1,2

Source: The Lancet Regional Health - Europe

DOI: 10.1016/j.lanepe.2026.101920

Authors: Bruno Sepodes, Juan Garcia Burgos, Steffen Thirstrup

Institutions: European Medicines Agency, University of Lisbon

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

Open Access status: gold

Estimated APC paid: $4,930

OpenAlex ID: W7225644095

FWCI:

Cites: 1

Cited by:

Related to: